Patents by Inventor Gerald Pohl

Gerald Pohl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
    Publication number: 20050107417
    Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: July 15, 2004
    Publication date: May 19, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Sabine Germeyer, Christopher Meade, Helmut Meissner, Gerd Morschhaeuser, Michel Pairet, Sabine Pestel, Michael Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Ingo Konetzki
  • Anticholinergics, processes for preparing them and pharmaceutical composition containing them
    Publication number: 20050054664
    Abstract: A compound of formula 1 wherein: A is a group selected from X? is an anion with a single negative charge; R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen; and R3, R4, R5, R6, R7, and R8 are each independently hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, CF3, CN, NO2, or halogen, with the proviso that at least one of the groups R3, R4, R5, R6, R7, and R8 is not hydrogen, processes for preparing these compounds, pharmaceutical compositions containing these compounds, and their use as pharmaceutical compositions.
    Type: Application
    Filed: October 21, 2004
    Publication date: March 10, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Helmut Meissner, Gerd Morschhaeuser, Michael Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
    Publication number: 20050043343
    Abstract: A pharmaceutical composition comprising: (a) a compound of formula 1 wherein X31 is an anion with a single negative charge; and (b) a PDE IV inhibitor, or an enantiomer, mixture of enantiomers, racemate, solvate, or hydrate thereof, processes for preparing them, and their use in the treatment of respiratory complaints.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 24, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Sabine Germeyer, Christopher Meade, Helmut Meissner, Gerd Morschhaeuser, Michel Pairet, Sabine Pestel, Michael Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Medicaments for inhalation comprising a novel anticholinergic and a steroid
    Publication number: 20050042176
    Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 24, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Sabine Germeyer, Christopher Meade, Helmut Meissner, Gerd Morschhaeuser, Michel Pairet, Sabine Pestel, Michael Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
    Patent number: 6852728
    Abstract: A compound of formula 1 wherein: A is a group selected from X? is an anion with a single negative charge; R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen; and R3, R4, R5, R6, R7, and R8 are each independently hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, CF3, CN, NO2, or halogen, with the proviso that at least one of the groups R3, R4, R5, R6, R7, and R8 is not hydrogen, processes for preparing these compounds, pharmaceutical compositions containing these compounds, and their use as pharmaceutical compositions.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: February 8, 2005
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Helmut Meissner, Gerd Morschhaeuser, Michael Paul Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
    Publication number: 20050020622
    Abstract: Fluorenecarboxylic acid esters of general formula 1 wherein X? and the groups A, R, R1, R2, R3, R3?, R4, and R4? have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.
    Type: Application
    Filed: August 9, 2004
    Publication date: January 27, 2005
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhaeuser, Sabine Pestel, Michael Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
    Patent number: 6815452
    Abstract: Fluorenecarboxylic acid esters of general formula 1 wherein X− and the groups A, R, R1, R2, R3, R3′, R4, and R4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: November 9, 2004
    Assignee: Boehringer Ingelheim Pharma KG & Co GmbH
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhaeuser, Sabine Pestel, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
    Patent number: 6806272
    Abstract: The present invention relates to new dihydropteridinones of the formula (I) wherein the groups X, R1, R2, R3, R4, R5 and R7 have the meanings given in the claims and the specification, the isomers thereof, processes and intermediates for preparing these dihydropteridinones as well as the use thereof as pharmaceutical compositions.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: October 19, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Eckhart Bauer, Steffen Breitfelder, Christian Eickmeier, Matthias Grauert, Matthias Hoffmann, Thorsten Lehmann-Lintz, Gerald Pohl, Jens Quant, Norbert Redemann, Gisela Schnapp, Martin Steegmaier
  • Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
    Patent number: 6790856
    Abstract: Flourenecarboxylic acid esters of general formula 1 wherein X− and the groups A, R, R1, R2, R3, R3′, R4, and R4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: September 14, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhaeuser, Sabine Pestel, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
    Publication number: 20040157832
    Abstract: Fluorenecarboxylic acid esters of general formula 1 1
    Type: Application
    Filed: February 5, 2004
    Publication date: August 12, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhauser, Sabine Pestel, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Anticholinergics which may be used as medicaments as well as processes for preparing them
    Publication number: 20040087617
    Abstract: The present invention relates to new anticholinergics of general formula 1 1
    Type: Application
    Filed: October 14, 2003
    Publication date: May 6, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Helmut Meissner, Gerd Morschhaeuser, Michael Paul Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Rolf Banholzer
  • Anticholinergics which may be used as medicaments as well as processes for preparing them
    Patent number: 6706726
    Abstract: The present invention relates to new anticholinergics of general formula 1: wherein A, X− and the groups R1, R2, R3, R4, R5, R6 and R7 may have the meanings given in the claims and in the specification, processes for preparing them and their use as pharamaceutical compositions.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: March 16, 2004
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Helmut Meissner, Gerd Morschhaeuser, Michael Paul Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Rolf Banholzer
  • New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
    Publication number: 20040029885
    Abstract: The present invention relates to new dihydropteridinones of the formula (I) 1
    Type: Application
    Filed: August 23, 2002
    Publication date: February 12, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Eckhart Bauer, Steffen Breitfelder, Christian Eickmeier, Matthias Grauert, Matthias Hoffmann, Thorsten Lehmann-Lintz, Gerald Pohl, Jens Quant, Norbert Redemann, Gisela Schnapp, Martin Steegmaier
  • Medicaments comprising betamimetics and a novel anticholinergic
    Publication number: 20040010003
    Abstract: A pharmaceutical composition comprising:
    Type: Application
    Filed: March 24, 2003
    Publication date: January 15, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet, Ingo Konetzki
  • Medicament combinations comprising heterocyclic compounds and a novel anticholinergic
    Publication number: 20040002502
    Abstract: The present invention relates to novel pharmaceutical compositions based on a new anticholinergic 1 and heterocyclic compounds 2, processes for preparing them and their use in the treatment of respiratory complaints.
    Type: Application
    Filed: April 8, 2003
    Publication date: January 1, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet
  • Medicaments comprising steroids and a novel anticholinergic
    Publication number: 20030223937
    Abstract: A pharmaceutical composition comprising:
    Type: Application
    Filed: March 19, 2003
    Publication date: December 4, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet
  • Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
    Publication number: 20030203928
    Abstract: Xanthenecarboxylates of formula 1 1
    Type: Application
    Filed: January 14, 2003
    Publication date: October 30, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH Co. KG
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhaeuser, Sabine Pestel, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
    Publication number: 20030199539
    Abstract: Flourenecarboxylic acid esters of general formula 1 1
    Type: Application
    Filed: January 2, 2003
    Publication date: October 23, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Sabine Germeyer, Helmut Meissner, Gerd Morschhaeuser, Sabine Pestel, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck
  • New esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
    Publication number: 20030199545
    Abstract: The present invention relates to new compounds of general formula 1 1
    Type: Application
    Filed: March 25, 2003
    Publication date: October 23, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Matthias Grauert, Michael P. Pieper, Gerald Pohl, Georg Speck, Steffen Breitfelder
  • Imidazotriazolopyrimidines with adenosine-antagonistic activity
    Patent number: 6492377
    Abstract: New imidazotriazolopyrimidine derivatives of the formula Preferred are those compounds wherein: R1 denotes methyl, which is optionally substituted by phenyloxy or pyrrole; or R1 denotes benzyl which is optionally substituted by hydroxy, methoxy, dimethylaminoethoxy or fluorine; or R1 denotes cyclopentyl, furan or phenylethyl; R2 or R3 denote ethyl, n-propyl, allyl or propargyl; R4 or R6 denote hydrogen; and, R5 denotes methyl, n-propyl, tert.butyl, cyclopentyl or norbornenyl. These are adenosine antagonists are are useful for, inter alia, the treatment of senile dementia of the Alzheimer's type.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: December 10, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Stefan Blech, Adrian Carter, Wolfram Gaida, Matthias Hoffmann, Ulrike Kuefner-Muehl, Christopher John Montague Meade, Gerald Pohl, Werner Kummer, Erich Lehr, Joachim Mierau, Thomas Weiser